MedPath

Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

Terminated
Conditions
Hypoglycemia
Neonatal Hypoglycemia
Registration Number
NCT04085978
Lead Sponsor
Pediatrix
Brief Summary

Evaluate if the implementation of a hypoglycemia protocol with glucose gel has reduced the NICU admission rate of neonates with low-acuity neonatal hypoglycemia.

Detailed Description

This project will evaluate various aspects of infants with hypoglycemia admitted to the Neonatal Intensive Care Unit (NICU) pre- and post- implementation of a hospital-wide hypoglycemia protocol with oral glucose gel. Subjects will be matched by gestational age (GA), birth weight rounded to the nearest half kilogram, ethnicity, gender, maternal age, maternal diabetes status, maternal parity, maternal ethnicity, and mode of delivery. Retrospective data will be reviewed including neonatal and maternal demographics and NICU medical course data. The results of this study can inform intended and unintended consequences of the instituted protocol.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • All neonates born at Banner University Hospital during January 01, 2014 - November 30, 2016 and January 01, 2018 - November 30 2018 who qualify for hypoglycemia protocol.
Exclusion Criteria
  • Neonates <34 weeks gestational age or with birth weight less than 2000 grams.
  • Infants with serious congenital malformation
  • Infants with a terminal disorder.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean maximum glucose infusion rate30 days

Mean maximum glucose infusion rate

Mean NICU length of stay rounded to the day30 days

Mean NICU length of stay rounded to the day

Secondary Outcome Measures
NameTimeMethod
Assess for weight loss30 days

- Maximum weight loss as percent below birth weight during NICU admission

Assess for complications30 days

- Number of neonates identified to have any type of infection

Evaluate for persistent symptomatic or asymptomatic hypoglycemia30 days

* Number of neonates with symptomatic hypoglycemia

* Number of neonates with asymptomatic hypoglycemia

Number of neonates who received formula30 days

Time to gain back to birthweight (if occurred while in-house), rounded to day of life

Number of neonates with any breastfeeding during hospitalization30 days

Time to gain back to birthweight (if occurred while in-house), rounded to day of life

Number of neonates with breastfeeding at time of discharge30 days

Time to gain back to birthweight (if occurred while in-house), rounded to day of life

Trial Locations

Locations (1)

Banner University Medical Center Phoenix

🇺🇸

Phoenix, Arizona, United States

Banner University Medical Center Phoenix
🇺🇸Phoenix, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.